Priming Tissue-specific Cellular Immunity in a Phase I Trial of Autologous Dendritic Cells for Prostate Cancer von Burch, P A, Breen, J K, Buckner, J C, Gastineau, D A, Kaur, J A, Laus, R L, Padley, D J, Peshwa, M V, Pitot, H C, Richardson, R L, Smits, B J, Sopapan, P, Strang, G, Valone, F H, Vuk-Pavlović, S

Volltext

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells von SMALL, Eric J, FRATESI, Paige, REESE, David M, STRANG, George, LAUS, Reiner, PESHWA, Madhusudan V, VALONE, Frank H

Volltext

P1028: PTG‐300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA von Kuykendall, A., Kremyanskaya, M., Ginsburg, Y., Pemmaraju, N., Ritchie, E., Gotlib, J., Valone, F., Khanna, S., Gupta, S., Hoffman, R., Verstovsek, S.

Volltext

Soluble normal and mutated DNA sequences from single-copy genes in human blood von Sorenson, G D, Pribish, D M, Valone, F H, Memoli, V A, Bzik, D J, Yao, S L

Volltext

Fluorouracil Modulation in Colorectal Cancer: Lack of Improvement With N -Phosphonoacetyl- l -Aspartic Acid or Oral Leucovorin or Interferon, But Enhanced Therapeutic Index With We... von O'DWYER, Peter J, MANOLA, Judith, BENSON, Al B, VALONE, Frank H, RYAN, Louise M, HINES, John D, WADLER, Scott, HALLER, Daniel G, ARBUCK, Susan G, WEINER, Louis M, MAYER, Robert J

Volltext

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu von VALONE, F. H, KAUFMAN, P. A, WARDWELL, K, GUYRE, V, MORLEY, T. L, ARVIZU, C, FANGER, M. W, GUYRE, P. M, LEWIS, L. D, MEMOLI, V, YASHWANT DEO, GRAZIANO, R, FISHER, J. L, MEYER, L, MROZEK-ORLOWSKI, M

Volltext

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer von Chong, G., Bhatnagar, A., Cunningham, D., Cosgriff, T. M., Harper, P. G., Steward, W., Bridgewater, J., Moore, M., Cassidy, J., Coleman, R., Coxon, F., Redfern, C. H., Jones, J. J., Hawkins, R., Northfelt, D., Sreedharan, S., Valone, F., Carmichael, J.

Volltext

Permanent Magnet Spiral Motor for Magnetic Gradient Energy Utilization: Axial Magnetic Field von Valone, Thomas F

Volltext

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin:... von F H Valone, M A Friedman, P S Wittlinger, T Drakes, P D Eisenberg, M Malec, J F Hannigan, B W Brown, Jr

Volltext

Proposed Use of Zero Bias Diode Arrays as Thermal Electric Noise Rectifiers and Non-Thermal Energy Harvesters von Valone, Thomas F

Volltext

Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma von Valone, FH, Epstein, LB

Volltext

Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer von Reid, Tony, Valone, Frank, Lipera, William, Irwin, David, Paroly, Warren, Natale, Ron, Sreedharan, Sunil, Keer, Harold, Lum, Bert, Scappaticci, Frank, Bhatnagar, Anish

Volltext

Identification of platelet-activating factor receptors in P388D1 murine macrophages von Valone, FH

Volltext

Mechanisms of platelet aggregation by viridans group streptococci von SULLAM, P. M, VALONE, F. H, MILLS, J

Volltext

A38 DIAMONDS ARE FOREVER BUT NEW TREATMENTS FOR INTERSTITIAL LUNG DISEASE CAN'T WAIT: Safety And Efficacy Of Anti-CTgf Monoclonal Antibody Fg-3019 For Treatment Of Idiopathic Pulmo... von Raghu, G, Scholand, M, De Andrade, J, Lancaster, L, Mageto, Y N, Goldin, J G, Porter, S, Neff, T B, Valone, F, Stauffer, J

Volltext

Specific binding of phospholipid platelet-activating factor by human platelets von Valone, FH, Coles, E, Reinhold, VR, Goetzl, EJ

Volltext

Binding of viridans group streptococci to human platelets: a quantitative analysis von SULLAM, P. M, PAYAN, D. G, DAZIN, P. F, VALONE, F. H

Volltext

Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial von Burch, Patrick A., Croghan, Gary A., Gastineau, Dennis A., Jones, Lori A., Kaur, Judith S., Kylstra, Jelle W., Richardson, Ronald L., Valone, Frank H., Vuk-Pavlović, Stanimir

Volltext

Review of Electrogravitics & Electrokinetics Propulsion von Valone, Thomas F.

Volltext

Role of immunoglobulin G in platelet aggregation by viridans group streptococci von SULLAM, P. M, JARVIS, G. A, VALONE, F. H

Volltext